WTX-212

N/A

Report date: 2024/12/20 16:50:59

Base Information

Drug NameWTX-212
Drug Alias NameWTX-212
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursLung NeoplasmsHematologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWestlake Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesWestlake Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsHematologic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A